Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ourofino Saúde Animal is a leading Brazilian pharmaceutical company dedicated to the development, manufacturing, and distribution of veterinary products for livestock and companion animals. The company operates one of the most modern industrial complexes in the animal health sector in Latin America, focusing on vaccines, antibiotics, anti-inflammatories, and antiparasitics. Ourofino plays a critical role in the Brazilian agribusiness ecosystem by providing integrated health solutions that enhance productivity in cattle, swine, and poultry farming. Their research and development efforts are geared toward innovative formulations and biological products tailored to tropical climates and specific regional disease pressures.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brazilian distributor of Livestock.